Skip to content
healthcare.dev

XELODA

NDC 61269-475, capecitabine, tablet, film coated, from H2-Pharma, LLC.

Product NDC
61269-475
Status
Listed
Labeler
H2-Pharma, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020896
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61269-475 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAPECITABINE500 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
61269-475-1261269047512120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61269-475-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e702d84d-7162-4751-bf37-d724cc7e45a5

Use it

Look up 61269-475 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61269-475 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61269-475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.